Skip to main content
Previous Poster Home Next

Real-world effectiveness of erythropoiesis-stimulating agents after luspatercept in patients with myelodysplastic syndromes: a retrospective analysis of a large healthcare claims database in the United States
07:30am - 03:35pm EST - April 6, 2024

  • Information
  • Resources
  • Play Recording

Real-world effectiveness of erythropoiesis-stimulating agents after luspatercept in patients with myelodysplastic syndromes: a retrospective analysis of a large healthcare claims database in the United States icon

Abstract: JNCCN23-0560 https://jnccn.org/view/journal...


Author(s):
  • Kashyap Patel, MD, Minnesota Oncology
  • Derek Tang, PhD, MS, BSPharm, Health Outcomes Research Leader, Bristol-Myers Squibb

Tags: Outcomes and Health Services Research

Display Label Action
High Resolution Poster_Hanna _NCCN 2024_ ESA post-lusp.pdf Download Handout
AC24P165 - Real-world effectiveness of erythropoiesis-stimulating agents after luspatercept in patients with myelodysplastic syndromes: a retrospective analysis of a large healthcare claims database in the United States Download MP3